Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease.

COBLEIGH M A; VOGEL C L; TRIPATHY D; ROBERT N J; SCHOOL S; FEHRENBACHER L; SHAK S; LIEBERMAN G; SLAMON D J

Art

J-GLOBAL ID：200902143070075617 Reference number：99A0935000

Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease.

転移性疾患に対する化学療法後に進行したHER2を過剰発現する転移性乳癌を有する女性におけるヒト化抗HER2モノクローナル抗体の有効性と安全性の多国籍研究

Publisher site Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=99A0935000&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=99A0935000&from=J-GLOBAL&jstjournalNo=E0307D") }}

Author (9)： , , , , , , , ,
Material：
Volume： 17 Issue： 9 Page： 2639-2648 Publication year： Sep. 1999
JST Material Number： E0307D ISSN： 0732-183X Document type： Article
Country of issue： United States (USA) Language： ENGLISH (EN)

, , , , , , , ,

Return to Previous Page